Condition-specific deactivation of brain regions by 5-HT3 receptor antagonist Alosetron

This publication has 35 references indexed in Scilit:

• Cilansetron shows efficacy in male and female non-constipated patients with irritable bowel syndrome in a United States study
  Gastroenterology, 2001
• The effect of the 5-HT3 receptor antagonist alosetron on regional brain activation in IBS patients is not dependent on activation of nociceptive visceral afferents: A H215O PET study
  Gastroenterology, 2001
• Cognitive and emotional influences in anterior cingulate cortex
  Trends in Cognitive Sciences, 2000
• Central processing of rectal pain in IBS patients: An fMRI study
  Gastroenterology, 2000
• Evidence for selective effect of the 5HT3 antagonist alosetron on amygdala and hippocampal activation in IBS patients
  Gastroenterology, 2000
• Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5‐HT₃ receptor antagonist
  Alimentary Pharmacology & Therapeutics, 1999
• Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome
  Alimentary Pharmacology & Therapeutics, 1998
• Contributions of anterior cingulate cortex to behaviour
  Brain, 1995
• Alosetron does not affect the visceral perception of gastric distension in healthy subjects
  Alimentary Pharmacology & Therapeutics, 1994
• Efficacy of Ondansetron (Gr 38032F) and the Role of Serotonin in Cisplatin-Induced Nausea and Vomiting
  New England Journal of Medicine, 1990